Insulin-like growth factor-1 downregulates nuclear factor κB activation and upregulates interleukin-8 gene expression induced by tumor necrosis factor α

Pretreatment of HT29-D4 epithelial adenocarcinoma colic cells with des-IGF-1 upregulated TNFα-mediated activation of IL-8 expression at different levels (protein, mRNA, and hnRNA). RNA transcription but not RNA stabilization was found to be involved. In this cell line, cooperation of NF-κB with othe...

Full description

Saved in:
Bibliographic Details
Published inBiochemical and biophysical research communications Vol. 305; no. 4; pp. 831 - 839
Main Authors Vallée, Sébastien, Fouchier, Francis, Brémond, Patricia, Briand, Claudette, Marvaldi, Jacques, Champion, Serge
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 13.06.2003
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Pretreatment of HT29-D4 epithelial adenocarcinoma colic cells with des-IGF-1 upregulated TNFα-mediated activation of IL-8 expression at different levels (protein, mRNA, and hnRNA). RNA transcription but not RNA stabilization was found to be involved. In this cell line, cooperation of NF-κB with other factors appeared essential for IL-8 expression. Indeed, TNFα-induced NF-κB translocation was not sufficient to support enhancement of the transcription and des-IGF-1 did not promote but partly inhibited both the TNFα-induced NF-κB activation and IκBα degradation through a PI-3K-dependent pathway. A CCAAT/enhancer binding protein (C/EBP) site located on the IL-8 gene enhancer cooperated with a NF-κB binding site and led to the upregulation of IL-8 expression. Binding of C/EBPα to this sequence disappeared in IGF-1 treated cells. This event may be important for the cross-talk between IGF-1- and TNFα-mediated pathways leading to the control of inflammatory processes and the decision concerning apoptosis or cell survival.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0006-291X
1090-2104
DOI:10.1016/S0006-291X(03)00866-0